Trial intelligence / Profile preview

Melatonin for Sleep Quality After Total Hip Arthroplasty

NCT07732725Phase 1Not yet recruiting

Sponsor
Benha University
Start
Aug 2026
Primary completion
Nov 2026
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of melatonin in sleep disorder (3 arms), sponsored by Benha University. Primary endpoint: Sleep Quality at 14 days. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

melatonin
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT07732725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07732725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call